Atrial fibrillation: A major risk factor for cognitive decline

Area of Science:

• Cardiology
• Neurology
• Geriatrics

Background:

• Atrial fibrillation (AF) is a prevalent condition in the elderly, associated with significant cardiovascular morbidity, mortality, and thromboembolic risks.
• Current management of AF focuses on anticoagulation, antiarrhythmic drugs, and rate control, with ablation and surgery as secondary options.
• Growing evidence indicates AF is a risk factor for cognitive decline, potentially exacerbating overall patient morbidity and mortality.

Purpose of the Study:

• To explore the association between atrial fibrillation and cognitive decline.
• To highlight the importance of cognitive screening and rhythm monitoring in patients with AF or cryptogenic strokes.
• To review the impact of current AF treatments on cognitive function and identify research gaps.

Main Methods:

• Literature review of studies investigating atrial fibrillation and cognitive function.
• Analysis of the interplay between AF, stroke, and cognitive impairment.
• Examination of existing and emerging therapeutic strategies for AF.

Main Results:

• Atrial fibrillation is linked to cognitive decline through various mechanisms, contributing to increased mortality.
• Cognitive decline in cryptogenic strokes may indicate undiagnosed atrial fibrillation.
• Current AF treatments may influence cognitive function, but further research is needed.

Conclusions:

• Integrated cognitive screening and cardiac rhythm monitoring are recommended for at-risk populations.
• Large-scale multicenter studies are required to evaluate the long-term cognitive effects of novel oral anticoagulants, rhythm/rate control strategies, and left atrial appendage occlusion.